EBS Emergent BioSolutions

NEUTRAL Impact: 2/10 PRESS-RELEASE
Horizon weeks Filed Jun 4, 2026 Processed 8d 22h ago Wire GlobeNewswire
Press release: contract
Latest settled — T+1d
EBS ▼ -4.38% at T+1d
NEUTRAL call ✗ call lost -4.38% · α vs SPY -1.79% · entry $8.44 → $8.07
Next anchor: T+5d due yesterday
Currently $8.32 · -1.42% from $8.44 entry
Entry anchored
Jun 4, 2026
via day open
T+1d
-4.38%
call -4.38% · α -1.79%
$8.07
settled 8d ago
T+5d
call — · α —
due yesterday
T+20d
call — · α —
in 20d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Emergent BioSolutions issued a press release announcing its partnership with Victoria's Voice Foundation for National Naloxone Awareness Day and promoting its NARCAN Nasal Spray and KLOXXADO products. The release is primarily a public awareness and branding initiative with no new financial data, contracts, or material business developments disclosed.

Actionable Insight

This is a routine public awareness campaign with no financial data — no immediate trading catalyst. Monitor for future earnings or contract announcements that may quantify the commercial impact of naloxone product sales.

Key Facts

  • Emergent is the presenting sponsor of National Naloxone Awareness Day on June 6, 2026, in partnership with Victoria's Voice Foundation.
  • The company is continuing its 'Ready to Rescue' initiative at colleges and universities with spokesperson Zac Clark.
  • Emergent is the leading U.S. supplier of nasal naloxone, offering NARCAN Nasal Spray 4 mg (OTC) and KLOXXADO Nasal Spray 8 mg (prescription).
  • No financial figures, revenue, earnings, guidance, or deal values were disclosed in the press release.

Financial Impact

No financial impact disclosed or estimable from the press release content.

Risk Factors

  • Opioid overdose reversal market faces potential pricing pressure and regulatory changes.
  • Competition from generic naloxone products could erode market share.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3306708
14 reports for EBS
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +14.89%Apr 29, 2026
Filters
Rows
Reports for EBS — sortable, filterable
Type Now
Jun 4, 2026
8d ago
Press Release
NEUTRAL ★ 2/10
$8.44 $8.07▼ −4.38%▼ −1.79%$8.32 (−1.42%)
Apr 30, 2026
6w ago
Press Release
MIXED ★ 6/10
$8.47 $8.54▲ +0.83%▲ +1.17%$8.32 (−1.77%)
Apr 30, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $8.47▲ +2.92%▲ +2.70%$8.32 (+1.09%)
Apr 29, 2026
6w ago
Press Release
BULLISH ★ 4/10
$7.99 $8.23▲ +3.00%▲ +1.98%$8.32 (+4.13%)
Apr 29, 2026
6w ago
Press Release
NEUTRAL ★ 1/10
$7.99 $8.23▲ +3.00%▲ +1.98%$8.32 (+4.13%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $7.99▼ −2.92%▼ −2.91%$8.32 (+1.09%)
Apr 28, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$8.23 $7.99▼ −2.92%▼ −2.91%$8.32 (+1.09%)
Apr 27, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.12▼ −1.34%▼ −1.33%$8.32 (+1.09%)
Apr 16, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$8.81 $8.35▼ −5.22%▼ −5.03%$8.32 (−5.56%)
Apr 16, 2026
8w ago
Press Release
BEARISH ★ 7/10
$8.81 $8.35▲ +5.22%▲ +5.03%$8.32 (+5.56%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (50h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access